![Chronic Lymphocytic Leukemia With Essential Thrombocythemia : Asbestos Exposure Association ? | Semantic Scholar Chronic Lymphocytic Leukemia With Essential Thrombocythemia : Asbestos Exposure Association ? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1c5755585d7c32f8ec4fbaa9d1133ae9b26ad9c6/2-Table1-1.png)
Chronic Lymphocytic Leukemia With Essential Thrombocythemia : Asbestos Exposure Association ? | Semantic Scholar
![Untreated essential thrombocythemia evolving to biphenotypic leukemia, Philadelphia chromosome positive with monosomy 7: response to imatinib and reduced-intensity allogeneic stem cell transplant | Leukemia Untreated essential thrombocythemia evolving to biphenotypic leukemia, Philadelphia chromosome positive with monosomy 7: response to imatinib and reduced-intensity allogeneic stem cell transplant | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.leu.2403725/MediaObjects/41375_2005_Article_BF2403725_Fig1_HTML.jpg)
Untreated essential thrombocythemia evolving to biphenotypic leukemia, Philadelphia chromosome positive with monosomy 7: response to imatinib and reduced-intensity allogeneic stem cell transplant | Leukemia
![Table 1 from Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. | Semantic Scholar Table 1 from Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e043f2527f0aeb10f838daeabfd6229c8e468e46/3-Table1-1.png)
Table 1 from Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. | Semantic Scholar
![Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders. | Semantic Scholar Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/33bc66fcb716b58e232e332ecd92e11de38c4ec5/2-TableI-1.png)
Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders. | Semantic Scholar
![Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases | Blood Cancer Journal Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00639-z/MediaObjects/41408_2022_639_Fig1_HTML.png)
Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases | Blood Cancer Journal
![A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients | BMC Cancer | Full Text A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6700-3/MediaObjects/12885_2020_6700_Fig1_HTML.png)
A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients | BMC Cancer | Full Text
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project | Haematologica
![Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia – ScienceOpen Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia – ScienceOpen](https://www.scienceopen.com/document_file/9bdd5d2a-9b36-4191-8d3f-341f057aec44/PubMedCentral/large.png)
Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia – ScienceOpen
![A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients | BMC Cancer | Full Text A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6700-3/MediaObjects/12885_2020_6700_Fig3_HTML.png)
A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients | BMC Cancer | Full Text
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project | Haematologica
![Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk‐stratification, and management - Tefferi - 2017 - American Journal of Hematology - Wiley Online Library Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk‐stratification, and management - Tefferi - 2017 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cfda2cfd-b96f-44c8-8b56-cf19a31dee85/ajh24607-fig-0003-m.jpg)
Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk‐stratification, and management - Tefferi - 2017 - American Journal of Hematology - Wiley Online Library
![How we diagnose and treat essential thrombocythaemia - Alimam - 2015 - British Journal of Haematology - Wiley Online Library How we diagnose and treat essential thrombocythaemia - Alimam - 2015 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aebe0116-2057-4261-8de6-362c025b33c1/bjh13605-fig-0001-m.jpg)